Background: Atrial fibrillation (AF) coexisting with coronary artery disease (CAD) remains a prevailing issue that often results in poor short- and long-term patient outcomes. Screening has been proposed as a method to increase AF detection rates and reduce the incidence of poor prognosis through early intervention. Nevertheless, due to the cost implications and uncertainty over the benefits of a systematic screening programme, the International Task Force currently recommends against screening. This study is to employ Bayesian networks (BN) for assessing the pre-test probability (PTP) of AF in patients with CAD.
Methods: A total of 12,552 patients with CAD were divided into the CAD patients with AF group (CHD-AF group) and the CAD patients without AF group (non-AF group). Univariate analysis and LASSO regression method were used to screen for potential risk factors. The maximum-minimum climb (MMHC) algorithm was used to construct the directed acyclic graph (DAG) of BN. Predictive power was tested using internal validation, external validation and 10-fold internal cross-validation. Finally, the generated BN model was compared with four machine learning algorithms.
Results: Fourteen indicators were included in the BN, including age, gender, systolic blood pressure (SBP), low-density lipoprotein cholesterol (LDL-C), serum uric acid (UA), gamma-glutamyltransferase (GGT), direct bilirubin (DBIL), lipoproteins [LP(a)], NYHA cardiac function grading, diabetes mellitus and hypertension, palpitation, dyspnoea and the left atrial diameter. The BN model performs well on both the test set (AUC = 0.90) and internal 10-fold cross-validation (AUC = 0.89 ± 0.01).
Conclusion: The prediction model of AF with CAD constructed based on BN has high prediction performance and may provide a new tool for large-scale AF screening.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11544742 | PMC |
http://dx.doi.org/10.1080/07853890.2024.2423789 | DOI Listing |
In Vivo
December 2024
Department of Health and Care Professions, Faculty of Health and Life Sciences, University of Exeter, Exeter, U.K.;
Background/aim: Atrial fibrillation (AF) and heart failure (HF) commonly co-occur, significantly increasing morbidity and mortality. Poorly controlled AF can contribute to complications like HF and is associated with conditions, such as stroke and pulmonary embolism (PE). This report involves a man with AF who had persistent respiratory symptoms and left-sided chest pain, initially suspected to be PE, but eventually diagnosed as HF.
View Article and Find Full Text PDFThromb Haemost
December 2024
Department of Brain Sciences, Imperial College London, London, United Kingdom.
Adequate secondary prevention in survivors of intracerebral hemorrhage (ICH) who also have atrial fibrillation (AF) is a long-standing clinical dilemma because these patients are at increased risk of recurrent ICH as well as of ischemic stroke. The efficacy and safety of oral anticoagulation, the standard preventive medication for ischemic stroke patients with AF, in ICH patients with AF are uncertain. PRESTIGE-AF is an international, phase 3b, multi-center, randomized, open, blinded end-point assessment (PROBE) clinical trial that compared the efficacy and safety of direct oral anticoagulants (DOACs) with no DOAC (either no antithrombotic treatment or any antiplatelet drug).
View Article and Find Full Text PDFClin Neurol Neurosurg
December 2024
Neurology department (I.N, M.F.B), Hassan II University Hospital, Fez, Morocco; Faculty of Medicine and Pharmacy, Sidi Mohammed Ben Abdallah University, Fez, Morocco.
Background: Silent brain infarctions (SBI) are commonly detected in brain imaging. The association of SBI with rheumatic mitral stenosis (MS) is not clearly relevant. Based on magnetic resonance imaging, we aimed to describe the prevalence of SBI in patients with rheumatic MS and the cardiac abnormalities related to their occurrence.
View Article and Find Full Text PDFAnn Noninvasive Electrocardiol
January 2025
Department of Cardiology, University Hospitals of Leicester NHS Trust, Glenfield Hospital, Leicester, UK.
Background: Pulmonary vein isolation (PVI) is the most promising management method for paroxysmal atrial fibrillation (PAF). The P wave in the electrocardiogram (ECG) represents atrial depolarization. This study aims to correlate P-wave parameters after PVI with outcomes.
View Article and Find Full Text PDFJ Cardiovasc Electrophysiol
December 2024
Centre for Cardiovascular Science, The University of Edinburgh, Edinburgh, UK.
Introduction: Atrial late gadolinium enhancement (Atrial-LGE) and electroanatomic voltage mapping (Atrial-EAVM) quantify the anatomical and functional extent of atrial cardiomyopathy. We aimed to explore the relationships between, and outcomes from, these modalities in patients with atrial fibrillation undergoing ablation.
Methods: Patients undergoing first-time ablation had disease severities quantified using both Atrial-LGE and Atrial-EAVM.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!